Page 85 - Cronos Group News Today

As the CEO of one of the largest companies in the world, Jeff Bezos’ endorsement of weed legalization carries weight.

Enbridge is eyeing expansion in South America, even as it continues fighting with the State of Michigan, which ordered the closure of a key pipeline.

Author Bio Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles. Tobacco giant Altria (NYSE:MO) has managed to attract investors to its stock despite a great many challenges. After all, the one-two punch of cons...

Hemp Derivatives Market 2021 Industry Growth, (Covid 19 Impact) Opportunity, Growth Factors and ongoing Trends till 2028

Not all cannabis stocks will have investors seeing green.

Shares of this troubled marijuana grower are finally on the move, but does it mean you should buy them?

BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced an amended collaboration and license agreement (the “Amended Agreement”) that will enable the companies to accelerate the commercialization of cultured cannabinoids at scale...

Cannabinoid company Cronos Group Inc. (NASDAQ:CRON

- Financialnewsmedia.com News Commentary PALM BEACH, Fla., June 3, 2021 /PRNewswire/ -- Over the past few years the legalization of marijuana has spurred the industry's growth in both medicinal

In its eighth year of operation, urban-gro stands out with over 30 experts on staff, ranging from engineers to environmental scien...